Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LlcfiledCriticalWyeth Llc
Priority to CU20100047ApriorityCriticalpatent/CU20100047A7/en
Publication of CU20100047A7publicationCriticalpatent/CU20100047A7/en
208000012902Nervous system diseaseDiseases0.000abstract1
208000015114central nervous system diseaseDiseases0.000abstract1
150000001875compoundsChemical class0.000abstract1
Landscapes
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención proporciona un compuesto de fórmula I y su uso para el tratamiento de un trastorno del sistema nervioso central relacionado con, o que se ve afectado por, el receptor de la histamina-3.The present invention provides a compound of formula I and its use for the treatment of a central nervous system disorder related to, or that is affected by, the histamine-3 receptor.
CU20100047A2010-03-122010-03-12
DERIVATIVES OF AZACICLILISOQUINOLINONA E-ISOINDOLINONA AS ANTAGONISTS OF HISTAMINE-3
CU20100047A7
(en)